Nifty 50
- JSW Steel₹1,32733.30 (2.57%)
- SBI Life Insurance ₹1,761.80-31.10 (-1.73%)
- Hindalco Industries₹1,058.5024.50 (2.37%)
- Bajaj Finance₹1,077-18.00 (-1.64%)
- Tata Steel₹186.303.30 (1.80%)
- Adani Ports₹1,672.10-27.90 (-1.64%)
- HCL Technologies₹1,32219.50 (1.50%)
- Bajaj Finserv₹2,001.70-30.80 (-1.52%)
- Dr. Reddy's Labs₹1,19015.30 (1.30%)
- Bharat Electronics₹409-5.00 (-1.21%)
- Tata Consumer ₹1,062.5013.50 (1.29%)
- Tata Motors PV₹314.40-3.50 (-1.10%)
- Bajaj Auto₹11,800100.00 (0.85%)
- Shriram Finance₹1,119-11.00 (-0.97%)
- Infosys₹1,1309.00 (0.80%)
- Max Healthcare₹990.50-9.50 (-0.95%)
- Hindustan Unilever₹2,03015.00 (0.74%)
- SBI₹1,039.50-9.20 (-0.88%)
- Eicher Motors₹8,04737.00 (0.46%)
- Jio Financial ₹242-2.00 (-0.82%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Laurus Labs Share Price
LAURUSLABS
₹1,801
Laurus Labs Performance
Price Movement
₹1790.00
₹1810.80
1 Year Performance
₹823.10
₹1870.80
Markets Today
Historical Performance
Summary
As of 24-08-2026 23:48, Laurus Labs Ltd. share price today is ₹0, with a change of ₹-1802.00 (-100.00%) from the previous close of ₹1802. The stock opened at ₹1800 and traded between ₹1790 and ₹1810.8, with a total traded volume of 2894242 shares. The company has a market capitalization of ₹97364.3 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1870.8 and ₹823.1, respectively.
Laurus Labs Ltd. valuation metrics include a P/E ratio of 89, EPS of ₹16.47, and book value of ₹17.20. Profitability indicators show ROE of 16.76% along with a dividend yield of 0.1%. Laurus Labs Ltd. has reported revenue of ₹7269.64 Cr and net profit of ₹1093.37 Cr.
Laurus Labs Ltd. technical indicators include Day RSI at 60.02, Day MFI at 43.08, Day ADX at 45.98. Additional indicators include Commodity Channel Index (CCI) at -4.1 and Williams %R at -67.85. Momentum indicators show Day MACD at 55.94, Day MACD Signal Line at 71.26, DayATR at 39.65. Rate of Change indicators for Laurus Labs Ltd. include ROC125 at 77.82 and ROC21 at 14.9.
Exponential moving averages include EMA5 at ₹1812.1, EMA10 at ₹1812.5, EMA12 at ₹1808.6, EMA20 at ₹1779.7, EMA26 at ₹1752.7, EMA50 at ₹1646.9, EMA100 at ₹1482, EMA200 at ₹1281.9. Simple moving averages include SMA5 at ₹1810.5, SMA10 at ₹1825.4, SMA20 at ₹1813.8, SMA30 at ₹1731.2, SMA50 at ₹1623.4, SMA100 at ₹1423.5, SMA150 at ₹1286, SMA200 at ₹1221.7.
Support levels for Laurus Labs are placed at First Support ₹1782.73, Second Support ₹1763.47, Third Support ₹1736.63. Resistance levels are seen at First Resistance ₹1828.83, Second Resistance ₹1855.67, Third Resistance ₹1874.93. Laurus Labs Ltd. shareholding pattern shows promoter holding at 27.47%, FII holding at 28%, DII holding at 0%, public holding at 30.79%.
Laurus Labs Fundamentals
Laurus Labs Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 1,757.16 | 1,580.30 | 1,509.42 | 1,566.60 | 1,432.75 |
| Operating Expense | 1,258.10 | 1,204.94 | 1,163.56 | 1,176.94 | 1,105.37 |
| Operating Profit | 499.06 | 375.36 | 345.86 | 389.66 | 327.38 |
| Depreciation | 95.76 | 95.17 | 94.31 | 95.59 | 93.57 |
| Interest | 35.20 | 33.91 | 31.48 | 33.68 | 43.89 |
| Tax | 98.21 | 67.58 | 59.36 | 73.17 | 53.50 |
| Net Profit | 289.96 | 191.79 | 175.08 | 215.67 | 157.94 |
Laurus Labs Technicals
Laurus Labs Ltd. EMA & SMA
₹1801.00
↗ Bullish Moving Average
10
↘ Bearish Moving Average
6
Laurus Labs Support and Resistance
Resistance
Support
Technical Indicators
Laurus Labs Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 27.6 | 27.6 | 27.6 | 27.5 | 27.5 | 27.5 |
| FII | 25.5 | 25.7 | 26.2 | 26.5 | 25.8 | 28 |
| DII | 11.8 | 11.9 | 11.7 | 12.4 | 14 | 13.7 |
| Public | 35.1 | 34.2 | 34.5 | 33.6 | 32.7 | 30.8 |
Laurus Labs Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 8.94 L | 14.46 L | 61.80% |
| Week | 8.6 L | 14.77 L | 58.24% |
| 1 Month | 10.79 L | 22.51 L | 47.94% |
| 6 Month | 11.51 L | 22.28 L | 51.67% |
Laurus Labs SWOT Analysis
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Expensive Stars (DVM)
Companies with 10% increase in share price over three months, with rising net profit growth
Consistent high performing stocks over Five Years
Relative Outperformance versus Industry over 1 Month
Rising Net Cash Flow and Cash from Operating activity
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Month
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every Quarter for the past 4 Quarters
Increasing profits every quarter for the past 4 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Near 52 Week High
Highest Recovery from 52 Week Low
RSI indicating price strength
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Laurus Labs Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 08 May, 2026 | 1.2 | INTERIM | 08 May, 2026 | Equity Share |
| 31 Oct, 2025 | 0.8 | INTERIM | 31 Oct, 2025 | Equity Share |
| 09 May, 2025 | 0.8 | INTERIM | 09 May, 2025 | Equity Share |
| 06 Nov, 2024 | 0.4 | INTERIM | 06 Nov, 2024 | Equity Share |
| 08 May, 2024 | 0.4 | INTERIM | 08 May, 2024 | Equity Share |
| 02 Nov, 2023 | 0.4 | INTERIM | 02 Nov, 2023 | Equity Share |
| 10 May, 2023 | 1.2 | INTERIM | 10 May, 2023 | Equity Share |
| 03 Nov, 2022 | 0.8 | INTERIM | 04 Nov, 2022 | Equity Share |
| 10 May, 2022 | 1.2 | INTERIM | 11 May, 2022 | Equity Share |
| 17 Nov, 2021 | 0.8 | INTERIM | 18 Nov, 2021 | Equity Share |
Laurus Labs Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,766 | ₹883.60 | ₹1,436.80 | ₹1,862 | ₹2,374.50 | ₹212.43 |
| % Change | 2.39% | 1.39% | -1.41% | -0.05% | -0.40% | -0.58% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 99.10 | 85.20 | 85.50 | 34.90 | 48.20 | -90.70 |
| 1 Year Return | 255.61 | 5.9 | 57.4 | 24.77 | -8.55 | 10.85 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3171.00
+0.06%
GLAND
Gland Pharma Ltd.
₹ 2811.90
-0.26%
ALKEM
Alkem Laboratories Ltd.
₹ 5350.00
-0.93%
BIOCON
Biocon Ltd.
₹ 409.40
-1.48%
DIVISLAB
Divi's Laboratories Ltd.
₹ 8496.00
-1.17%
GRANULES
Granules India Ltd.
₹ 857.00
-0.13%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3581.00
-1.62%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1103.80
-1.45%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2390.70
+3.14%
WOCKPHARMA
Wockhardt Ltd.
₹ 1902.00
+0.83%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1608.00
-0.82%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1910.00
+0.40%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 22901.00
-1.72%
IPCALAB
Ipca Laboratories Ltd.
₹ 1921.00
+0.51%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2930.00
+0.96%
PFIZER
Pfizer Ltd.
₹ 4886.00
-1.85%
ABBOTINDIA
Abbott India Ltd.
₹ 26450.00
+0.84%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4886.50
-0.20%
LUPIN
Lupin Ltd.
₹ 2188.00
-0.63%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1190.00
+1.30%
CIPLA
Cipla Ltd.
₹ 1437.90
+0.40%
FAQ's on LAURUSLABS
What is the current share price of Laurus Labs Ltd.?
What is the Market Capitalization of Laurus Labs Ltd.?
What are the PE and PB ratios for Laurus Labs Ltd.?
What is the 52-Week High and Low for Laurus Labs Ltd.?
What is the current dividend yield for Laurus Labs Ltd.?
Who are the major shareholders of Laurus Labs Ltd.?
- Public
- FII
- Promoter
- Mutual Funds
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Laurus Labs Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Laurus Labs Ltd.?
By signing up I certify terms, conditions & privacy policy